“Classified research constitutes a much smaller portion of the U.S. biodefense program than many might suspect,” according to Gerald L. Epstein, a specialist at the Center for Strategic and International Studies.
“Nevertheless, classified DHS biodefense research will constitute one of the most controversial parts of the U.S. biodefense program,” he observed in Congressional testimony (pdf) earlier this month.
“Even more so than in other areas of science, the biological sciences have enjoyed a tradition of openness and international collaboration–and this heavy presumption of openness should continue. Since disease continues to kill millions of people around the world each year, any restrictions on relevant scientific knowledge could have serious consequences,” he told a House Science Subcommittee.
“Yet the existence of hostile, witting adversaries that are determined to wreak devastation and that are known to be interested in biological weapons mandates that this openness not be absolute.”
In March 8 testimony (at pp. 6-8), Dr. Epstein presented his views on how to reconcile these conflicting imperatives.
Successful NC3 modernization must do more than update hardware and software: it must integrate emerging technologies in ways that enhance resilience, ensure meaningful human control, and preserve strategic stability.
The FY2026 National Defense Authorization Act (NDAA) paints a picture of a Congress that is working to both protect and accelerate nuclear modernization programs while simultaneously lacking trust in the Pentagon and the Department of Energy to execute them.
For Impact Fellow John Whitmer, working in public service was natural. “I’ve always been around people who make a living by caring.”
While advanced Chinese language proficiency and cultural familiarity remain irreplaceable skills, they are neither necessary nor sufficient for successful open-source analysis on China’s nuclear forces.